Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?

World J Surg. 1992 Jul-Aug;16(4):640-5; discussion 645-6. doi: 10.1007/BF02067343.

Abstract

From 1964 to 1989, bone metastases were found in 28 of 600 patients operated on for differentiated thyroid carcinoma. Bone metastasis was the presenting symptom in 15 (54%) patients, was detected from the initial symptom in 4 (14.5%) patients, and occurred subsequently in 9 (32%) patients, with an average lag time of 4.5 years after surgical treatment. Pathological pattern of the thyroid cancer was follicular in 26 (93%) patients and papillary in 2 (7%) patients. Bone metastatic involvement was multiple in 21 (75%) patients and associated with other synchronous or metachronous distant metastases in 13 (46%) patients, especially in the lung (10 patients) or the brain (3 patients). The primary treatment of thyroid carcinoma was total thyroidectomy in all 28 patients, with additional modified neck dissection in 8 patients. All 15 patients presenting with symptoms had bone metastases demonstrated by x-ray studies. Six of the bone metastases only took up radioactive iodine 6 weeks after total thyroidectomy, as did 2 of 4 bone metastases detected at initial observation and 4 of 9 metachronous bone metastases. All 12 patients with functioning bone metastases were given radioactive iodine therapy; 4 of the metastases were surgically resected. Only 2 patients with bone metastases showed a complete response after an ablative dose of I-131; none of the metastases had been demonstrated by x-ray studies. Radioactive iodine therapy cures no more than 17% of patients with bone metastases taking up radioactive iodine and 7% of all patients with bone metastases. All patients cured of bone metastases were given radioactive iodine, either alone, or combined with other treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH terms

  • Adenocarcinoma / radiotherapy*
  • Adenocarcinoma / secondary*
  • Adenocarcinoma / surgery
  • Adolescent
  • Adult
  • Aged
  • Bone Neoplasms / radiotherapy*
  • Bone Neoplasms / secondary*
  • Bone Neoplasms / surgery
  • Carcinoma, Papillary / radiotherapy*
  • Carcinoma, Papillary / secondary*
  • Carcinoma, Papillary / surgery
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Iodine Radioisotopes / therapeutic use*
  • Male
  • Middle Aged
  • Palliative Care
  • Postoperative Care
  • Retrospective Studies
  • Thyroid Neoplasms / pathology*
  • Thyroid Neoplasms / surgery
  • Thyroidectomy
  • Treatment Outcome

Substances

  • Iodine Radioisotopes